PULM Logo

Pulmatrix, Inc. (PULM) 

NASDAQ
Market Cap
$22.35M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
680 of 774
Rank in Industry
369 of 432

Largest Insider Buys in Sector

PULM Stock Price History Chart

PULM Stock Performance

About Pulmatrix, Inc.

Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug for the treatment of allergic …

Insider Activity of Pulmatrix, Inc.

Over the last 12 months, insiders at Pulmatrix, Inc. have bought $0 and sold $0 worth of Pulmatrix, Inc. stock.

On average, over the past 5 years, insiders at Pulmatrix, Inc. have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,150,000 shares for transaction amount of $224,608 was made by MCGUIRE TERRANCE () on 2018‑04‑03.

List of Insider Buy and Sell Transactions, Pulmatrix, Inc.

2018-04-03Purchase
1.15M
0.9862%
$0.20$224,608-22.17%
2018-04-03Purchasedirector
1.15M
3.2822%
$0.65$747,500-22.17%
2018-04-03Purchasedirector
307,000
0.8762%
$0.65$199,550-22.17%
2018-04-03Purchasedirector
20,000
0.0571%
$0.65$13,000-22.17%
2015-06-17Sale10 percent owner
922,500
3.7852%
$2.75$2.54M-66.53%
2015-06-16Sale10 percent owner
727,500
3.023%
$2.75$2M-66.10%
2015-06-16Purchasedirector
72,750
0.7558%
$6.88$500,156-66.10%
2015-06-16Purchasedirector
38,805
0.4031%
$6.88$266,784-66.10%
2015-06-16Purchasedirector
36,375
0.3779%
$6.88$250,078-66.10%
2015-06-15Purchase
74,036
0.7174%
$6.88$508,998-68.30%
2015-03-23Sale10 percent owner
350,000
0.2347%
$2.75$962,500-51.06%

Insider Historical Profitability

<0.0001%
MCGUIRE TERRANCE
3468190
94.9593%
$6.1220<0.0001%
GILLIS STEVENdirector
3436456
94.0904%
$6.1220<0.0001%
ROCKLAGE SCOTT Mdirector
1192154
32.6413%
$6.1210
Iwicki Mark Tdirector
307000
8.4057%
$6.1210<0.0001%
Maki Daviddirector
218194
5.9742%
$6.1210

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Renaissance Technologies$201,000.003.14114,820-2.13%-$4,378.17<0.0001
BlackRock$96,073.001.554,899<0.01%-$1.75<0.0001
The Vanguard Group$61,394.000.9635,0820%+$0<0.0001
Geode Capital Management$41,203.000.6824,6600%+$0<0.0001
State Street$23,288.000.3813,9450%+$0<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.